IUS Publications

A. Arslan, “Application of neuroimaging in the diagnosis and treatment of depression”, in Understanding Depression , vol. Volume 2. Clinical Manifestations, Diagnosis and Treatment, 2 vol., Heidelberg: Springer Nature, 2018, pp. 69-81.

O. Aydın, Ünal-Aydın, P., and Arslan, A., “"Development of neuroimaging–based biomarkers in psychiatry"”, in Advances in Experimental Medicine and Biology (Edited by Kim YK), vol. vol 1192, Singapore: Springer , 2019, pp. 159-195.

A. Arslan, Ünal-Aydın, P., doğan, taner, and Aydın, O., “Optogenetic Animal Models of Depression: From Mice to Men”, in Kim YK., Amidfar M. (eds) Translational Research Methods for Major Depressive Disorder. Neuromethods., vol. 179, New York, NY: Humana Press , 2022, pp. 167-191.

A. Arslan, “Clustering of GABA (A) receptors ”, in The Fourth Regional Conference on Soft Computing: IUSSCRG 2015, 26-27 June, 2015, Sarajevo, Bosnia and Herzegovina (Key note speaker), 2015.

A. Arslan, “The Meaning of Human Genome Project”, in International Conference on Engineering and Natural Sciences, 9-11 Sept. 2015, Sarajevo, Bosnia and Herzegovine (Key note speaker), 2015, (Abstract).

A. Arslan, “A molecular biologist’s view on halal food authenticity”, in World Halal Summit 2018, Istanbul Turkey, 2019.

A. Arslan, “The biological revolution”, Periodicals of Engineering and Natural Sciences, vol. 3, no. 1, 2015.

A. Arslan, “Clustering of GABA (A) receptors”, Periodicals of Engineering and Natural Sciences, vol. 3, no. 1, 2015.

A. Arslan, “The complexity of mental disorders”, Periodicals of Engineering and Natural Sciences, vol. 3, no. 1, 2015.

A. Arslan, “Distinct roles of gamma-aminobutyric acid type A receptor subtypes: A focus on phasic and tonic inhibition”, The Journal of Neurobehavioral Sciences, vol. 2, no. 2, 2015.

M. Aslankara, Bayram, A., Tarhan, N., and Arslan, A., “Effect of ovarian hormones on memory suppression”, The Journal of Neurobehavioral Sciences, vol. 1, no. 3, pp. 1-4, 2014.

A. Arslan, “Genes, Brains and Behavior: Imaging Genetics for Neuropsychiatric Disorders”, The Journal of Neuropsychiatry and Clinical Neurosciences (SCI), vol. 27, no. 2, pp. 81-92, 2015.

P. Ünal-Aydın, Aydın, O., and Arslan, A., “Genetic Architecture of Depression: Where do we stand now?”, Adv Exp Med Biol, Major Depressive Disorder, Springer Nature , vol. 1305, pp. 203–230., 2021.

A. Arslan, “Imaging genetics of schizophrenia in the post-GWAS era (top 10 % of all papers of 2018 within the field of "Psychiatry; Pharmacology; Pharmacology& Pharmacy; Neurosciences; Clinical Neurology", according to Web of science (WOS)”, Progress in Neuro-Psychopharmacology and Biological Psychiatry (science citation index, Impact Factor: 4.320), vol. pii: S0278-5846(17)30071-4. , 2018.

A. Arslan, “Mapping the schizophrenia genes by neuroimaging: The promises and the challenges,”, International Journal of Molecular Sciences -invited author- (SCIE) Impact Factor: 3.226, vol. 11;19(1). , 2018.

F. E. Oflaz, Son, Ç. D., and Arslan, A., “Oligomerization and cell surface expression of recombinant GABA (A) receptors tagged in the δ subunit (science citation index expanded, impact factor: 1.17)”, J Integr Neurosc, vol. 18, no. 4, pp. 341-350, 2019.

L. - N. Smajovic, Oflaz, F. Enes, and Arslan, A., “A study of the CaCl2 induced E. coli DH5-Alpha transformation by heat shock accompanied by vibration.”, IFMBE Proceedings , 2021.

A. Arslan, “Genethics today, Round Table Discussion, World Bioethics Day, IUS”. 2017.

A. Arslan, “'Halal Food and Health Care panel- "Molecular biology solutions for Halal authentication in food and pharmaceutical industry: A focus on the Gelatin" , Sarajevo Halal Fair, September 29, 2018,, Sarajevo, Bosnia and Herzegovina”. 2018.